home
HOME 

  WELCOME
 
The Mount Sinai Community Clinical Oncology Program (MSCCOP) is a nonprofit community-based program committed to providing novel clinical research to cancer treatment patients and to healthy individuals who may be at risk for cancer.

CCOP is a comprehensive organized clinical trials mechanism for disseminating the latest cancer prevention and treatment research findings to the community level. The aim of the program is to provide cancer patients with access to NCI-sponsored cancer treatment trials and up to date cancer management in patients’ own communities. The program increases the number of patients and physicians who can participate in clinical trials operated at major research centers, and allows scientists to conduct large-scale cancer prevention and control studies. read more ...

 
Newest Protocols
Small Cell Lung Cancer (CALGB 30504): COMBINATION CISPLATIN, ETOPOSIDE AND SUNITINIB MALATE FOR UNTREATED EXTENSIVE STAGE SMALL C...
Cat: Respiratory (05/05/2009)
NSCLC (RTOG 0617): A Randomized Phase III Comparison of Standard- Dose (60 Gy) Versus High-Dose (74 Gy) Confor...
Cat: Respiratory (04/10/2009)
BRAIN (RTOG 0614): A RANDOMIZED, PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MEMANTINE FOR PREVENTION...
Cat: Brain (03/02/2009)
Latest Announcements
RTOG 0524-Temporarily Suspended to Accrual
CALGB 80101- Closed To Accrual
ECOG E5202 (Suspended To Accrual)
more ...
 



©2004 MSCCOP & Mount Sinai Medical Center